Clinical Trial Update: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. [Phase 1]

View source ↗

Summary

Phase 1 double-blind, placebo-controlled trial evaluating psilocybin for obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yale University | Conditions: Obsessive-Compulsive Disorder | Phase 1 | Status: COMPLETED